Rear-Facing Car Safety Seat Use for Children 18 Months of Age: Prevalence and Determinants

被引:5
|
作者
Jones, Ashley T. [1 ]
Hoffman, Benjamin D. [1 ,2 ]
Gallardo, Adrienne R. [2 ]
Gilbert, Tess A. [3 ]
Carlson, Kathleen F. [3 ]
机构
[1] Oregon Hlth & Sci Univ, Dept Pediat, Sch Med, Doernbecher Childrens Hosp, 3181 Sw Sam Jackson Pk Rd, Portland, OR 97201 USA
[2] Doernbecher Childrens Hosp, Tom Sargent Childrens Safety Ctr, Portland, OR USA
[3] OHSU PSU, Sch Publ Hlth, 840 SW Gaines St, Portland, OR USA
来源
JOURNAL OF PEDIATRICS | 2017年 / 189卷
基金
美国国家卫生研究院;
关键词
PASSENGER SAFETY; PARENTS; SYSTEM; MISUSE; STATES;
D O I
10.1016/j.jpeds.2017.06.020
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Objective To examine the prevalence and potential determinants of rear-facing car safety seat use among children approximately 18 months of age born at a university hospital. Study design We administered a telephone survey to caregivers of children 17-19 months of age who were born between November 2013 and May 2014. The survey was designed to assess the prevalence of rear-facing car safety seat use and estimate the likelihood of rear-facing car safety seat use, compared with forward-facing car seat use, in reference to hypothesized determinants. aORs and 95% CIs were calculated using multivariable logistic regression. Results In total, 56% of potentially eligible caregivers (491/877) completed the survey; 62% of these reported rear-facing car safety seat use. Race, education, rurality, and household income were associated with rear-facing car safety seat use after controlling for potential confounders. Additionally, caregivers who reported having discussed car seats with their child's provider (aOR 1.7; 95% CI 1.1-2.6); receiving their child's primary care in pediatrics compared with family practice clinics (aOR 2.4; 95% CI 1.1-2.6); and being aware of the American Academy of Pediatrics rear-facing recommendation (aOR 2.8; 95% CI 1.8-4.1) were significantly more likely to report rearfacing car safety seat use. Conversely, caregivers who previously used a car seat with another child were less likely to have their child rear facing at 18 months of age (aOR 0.6; 95% CI 0.4-0.9). Conclusions A large proportion of children were forward facing at 18 months of age. Future efforts focused on encouraging providers to discuss car seats during patient visits, increasing awareness of the American Academy of Pediatrics' rear-facing recommendation, and targeting high-risk populations may improve the prevalence of children who remain rear facing until 2 years of age.
引用
收藏
页码:189 / +
页数:16
相关论文
共 36 条
  • [21] Safety and immunogenicity of an oral, inactivated enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine in Bangladeshi children 18-36 months of age
    Qadri, F
    Ahmed, T
    Ahmed, F
    Sack, RB
    Sack, DA
    Svennerholm, AM
    VACCINE, 2003, 21 (19-20) : 2394 - 2403
  • [22] SAFETY EVALUATION OF PRP-D HAEMOPHILUS-INFLUENZAE TYPE B CONJUGATE VACCINE IN CHILDREN IMMUNIZED AT 18 MONTHS OF AGE AND OLDER - FOLLOW-UP-STUDY OF 30000 CHILDREN
    VADHEIM, CM
    GREENBERG, DP
    MARCY, SM
    FROESCHLE, J
    WARD, JI
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1990, 9 (08) : 555 - 561
  • [23] Primary Health Care during the COVID-19 pandemic in Fortaleza, Brazil: associated factors and pattern of use by mothers and children up to 18 months of age
    Correia, Luciano Lima
    Machado, Marcia Maria Tavares
    Araujo, David Augusto Batista Sa
    Gomes, Yuri Valentim Carneiro
    Pinheiro, Maria Suelly Nogueira
    Rocha, Hermano Alexandre Lima
    Nogueira, Denise Lima
    de Sousa, Geziel dos Santos
    Farias-Antunez, Simone
    Castro, Marcia Caldas
    REVISTA BRASILEIRA DE EPIDEMIOLOGIA, 2022, 25
  • [24] Prevalence and determinants of anemia due to micronutrient deficiencies among children aged 12-59 months in India-Evidence from Comprehensive National Nutrition Survey, 2016-18
    Yadav, Kapil
    Ramaswamy, Gomathi
    Puri, Surabhi
    Vohra, Kashish
    Achary, Thejas
    Jaiswal, Abhishek
    Kaur, Ravneet
    Bairwa, Mohan
    Singh, Archana
    Sethi, Vani
    PLOS GLOBAL PUBLIC HEALTH, 2024, 4 (01):
  • [25] SAFETY OF H-INFLUENZAE TYPE-B (HIB) CONJUGATE VACCINE (PRP-D) IN 15,713 CHILDREN 18-60 MONTHS OF AGE
    GREENBERG, DP
    VADHEIM, CM
    MARCY, SM
    WARD, JI
    PEDIATRIC RESEARCH, 1989, 25 (04) : A179 - A179
  • [26] Safety and immunogenicity of high doses of quadrivalent influenza vaccine in children 6 months through <18 years of age: A randomized controlled phase II dose-finding trial
    Chang, Lee-Jah
    Anderson, Evan J.
    Jeanfreau, Robert
    He, Ying
    Hicks, Bryony
    Shrestha, Anju
    Pandey, Aseem
    Landolfi, Victoria
    DeBruijn, Iris
    VACCINE, 2021, 39 (11) : 1572 - 1582
  • [27] A Phase 3, Single-arm Trial to Evaluate the Safety and Immunogenicity of a 20-Valent Pneumococcal Conjugate Vaccine in Healthy Children 15 Months Through <18 Years of Age
    Meyer, Jay
    Silas, Peter
    Ouedraogo, G. Laissa
    McElwee, Kathleen
    Keep, Georgina
    Trammel, James
    Peng, Yahong
    Scully, Ingrid L.
    Gruber, William C.
    Scott, Daniel A.
    Watson, Wendy
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2024, 43 (06) : 574 - 581
  • [28] Time trends in the prevalence and determinants of age-appropriate breast feeding among children aged 0-23 months in Ghana: a pooled analysis of population-based surveys, 2003-2017
    Mohammed, Shamsudeen
    Oakley, Laura L.
    Marston, Milly
    Glynn, Judith R.
    Calvert, Clara
    BMJ OPEN, 2022, 12 (08):
  • [29] Association of soap use when bathing 18-month-old infants with the prevalence of allergic diseases at age 3 years: The Japan Environment and Children's Study
    Kato, Taisuke
    Adachi, Yuichi
    Tsuchida, Akiko
    Matsumura, Kenta
    Murakami, Shokei
    Shimizu, Muneyuki
    Wada, Takuya
    Okabe, Hisao
    Hashimoto, Koichi
    Hosoya, Mitsuaki
    Inadeara, Hidekuni
    PEDIATRIC ALLERGY AND IMMUNOLOGY, 2023, 34 (04)
  • [30] Gabapentin as add-on to morphine for severe neuropathic or mixed pain in children from age 3 months to 18 years - evaluation of the safety, pharmacokinetics, and efficacy of a new gabapentin liquid formulation: study protocol for a randomized controlled trial
    Thomas G. de Leeuw
    Laura Mangiarini
    Rebecca Lundin
    Florentia Kaguelidou
    Tjitske van der Zanden
    Oscar Della Pasqua
    Dick Tibboel
    Adriana Ceci
    Saskia N. de Wildt
    Trials, 20